THE ACAAI/AAAAI ALLERGEN IMMUNOTHERAPY (AIT) SAFETY SURVEILLANCE STUDY: YEAR 6 (2013-2014)

被引:0
|
作者
Bernstein, D.
Murphy, K.
Liss, G.
Epstein, T.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P064
引用
收藏
页码:S40 / S41
页数:2
相关论文
共 32 条
  • [1] FATAL AND SYSTEMIC REACTIONS TO SUBCUTANEOUS ALLERGEN IMMUNOTHERAPY: ACAAI/AAAAI NATIONAL SURVEILLANCE STUDY AFTER ONE YEAR
    Epstein, T. G.
    Murphy, K.
    Liss, G. M.
    Bernstein, D. I.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A23 - A24
  • [2] The Impact of Asthma Control and Higher Maintenance Doses on Immunotherapy Safety: Year 5 of the AAAAI/ACAAI Surveillance Study
    Epstein, Tolly
    Liss, Gary M.
    Murphy-Berendts, Karen J.
    Bernstein, David I.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB215 - AB215
  • [3] Safety of allergen immunotherapy in North America from 2008-2017: Lessons learned from the ACAAI/AAAAI National Surveillance Study of adverse reactions to allergen immunotherapy
    Bernstein, David, I
    Epstein, Tolly E. G.
    [J]. ALLERGY AND ASTHMA PROCEEDINGS, 2020, 41 (02) : 108 - 111
  • [4] Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI Collaborative Study
    Bernstein, David I.
    Epstein, Tolly
    Murphy-Berendts, Karen
    Liss, Gary M.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2010, 104 (06) : 530 - 535
  • [5] AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?
    Epstein, Tolly G.
    Liss, Gary M.
    Murphy-Berendts, Karen
    Bernstein, David I.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2013, 110 (04) : 274 - +
  • [6] AAAAI Membership Experience with Allergen Immunotherapy (AIT) Safety in Young Children and Pregnant Women
    Rank, Matthew A.
    Hauswirth, David W.
    Calabria, Christopher W.
    Sher, Lawrence D.
    Linnemann, Desiree E. S. Larenas
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (02) : AB186 - AB186
  • [7] AAAAI/ACAAI Surveillance Study of Subcutaneous Immunotherapy (SCIT) injections (Year 2): Time of Onset and Treatment of Systemic Reactions (SRs)
    Epstein, T.
    Bernstein, D. I.
    Murphy, K.
    Liss, G. M.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB218 - AB218
  • [8] AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): Fatalities, Infections, Delayed Reactions, and Use of Epinephrine Autoinjectors
    Epstein, Tolly G.
    Liss, Gary M.
    Berendts, Karen Murphy
    Bernstein, David I.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (06): : 1996 - +
  • [9] Immediate and delayed-onset systemic reactions after subcutaneous immunotherapy injections: ACAAI/AAAAI surveillance study of subcutaneous immunotherapy-year 2
    Epstein, Tolly G.
    Liss, Gary M.
    Murphy-Berendts, Karen
    Bernstein, David I.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2011, 107 (05) : 426 - 431
  • [10] AAAAI membership experience with allergen immunotherapy (AIT) safety in patients with special medical conditions varies according to practice characteristics
    Larenas Linnemann, D. E. S.
    Rank, M.
    Calabria, C. W.
    Sher, L. D.
    Hauswirth, D. W.
    [J]. ALLERGY, 2014, 69 : 510 - 511